Skip to content

Septerna, Inc. SEPN Debt-to-assets

Debt-to-assets at other companies

Amgen logo
AmgenAMGN
0.6×0.0×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
0.0×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
0.1×0.0×
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
0.0×
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
0.4×0.0×
Precigen logo
PrecigenPGEN
0.7×+0.7×

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s debt-to-assets?
Septerna, Inc. (SEPN) reported debt-to-assets of 0× in Q1 2026.
How has Septerna, Inc.'s debt-to-assets changed year-over-year?
Septerna, Inc.'s debt-to-assets decreased by 29.8% year-over-year, from 0.1× to 0×.
What is the long-term trend for Septerna, Inc.'s debt-to-assets?
Over 2 years (2023 to 2025), Septerna, Inc.'s debt-to-assets has grown at a -35.8% compound annual growth rate (CAGR), from 0.1× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.